Wright Medical Group N.V. (NASDAQ:WMGI)‘s stock had its “buy” rating restated by research analysts at Jefferies Group LLC in a research note issued to investors on Friday.

A number of other research firms also recently weighed in on WMGI. Oppenheimer Holdings, Inc. set a $30.00 target price on Wright Medical Group N.V. and gave the stock a “hold” rating in a research report on Thursday, August 3rd. BidaskClub downgraded shares of Wright Medical Group N.V. from a “hold” rating to a “sell” rating in a research note on Saturday, August 5th. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $30.00 price target on shares of Wright Medical Group N.V. in a research note on Thursday. BMO Capital Markets dropped their price target on shares of Wright Medical Group N.V. from $34.00 to $31.00 and set an “outperform” rating on the stock in a research note on Thursday. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Wright Medical Group N.V. in a report on Thursday. Six investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $31.50.

Wright Medical Group N.V. (NASDAQ:WMGI) last posted its earnings results on Wednesday, November 1st. The medical device company reported ($0.16) EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.16). The company had revenue of $170.50 million during the quarter, compared to analyst estimates of $173.50 million. Wright Medical Group N.V. had a negative return on equity of 5.99% and a negative net margin of 38.40%. The business’s revenue was up 8.4% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.19) earnings per share.

WARNING: This report was first published by American Banking News and is owned by of American Banking News. If you are reading this report on another site, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/11/03/jefferies-group-llc-reiterates-buy-rating-for-wright-medical-group-n-v-wmgi.html.

Institutional investors have recently added to or reduced their stakes in the company. Blue Jay Capital Management LLC increased its stake in shares of Wright Medical Group N.V. by 4.7% during the 2nd quarter. Blue Jay Capital Management LLC now owns 320,420 shares of the medical device company’s stock worth $8,808,000 after purchasing an additional 14,255 shares during the last quarter. Victory Capital Management Inc. increased its stake in shares of Wright Medical Group N.V. by 30.6% during the 2nd quarter. Victory Capital Management Inc. now owns 1,039,308 shares of the medical device company’s stock worth $28,571,000 after purchasing an additional 243,630 shares during the last quarter. Capital Research Global Investors boosted its holdings in shares of Wright Medical Group N.V. by 60.9% during the 2nd quarter. Capital Research Global Investors now owns 2,775,000 shares of the medical device company’s stock worth $76,285,000 after buying an additional 1,050,000 shares during the period. Westfield Capital Management Co. LP boosted its holdings in shares of Wright Medical Group N.V. by 13.8% during the 2nd quarter. Westfield Capital Management Co. LP now owns 2,425,566 shares of the medical device company’s stock worth $66,679,000 after buying an additional 293,687 shares during the period. Finally, Macquarie Group Ltd. boosted its holdings in shares of Wright Medical Group N.V. by 35.4% during the 2nd quarter. Macquarie Group Ltd. now owns 1,225,352 shares of the medical device company’s stock worth $33,685,000 after buying an additional 320,087 shares during the period.

Wright Medical Group N.V. Company Profile

Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.

Analyst Recommendations for Wright Medical Group N.V. (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group N.V. and related companies with MarketBeat.com's FREE daily email newsletter.